List is sorted by tweets
Rating (?)
Tweets (*)
pr *
  • Dyadic International, Inc
  • www.dyadic.com
  • Develops biological products such as proteins, enzymes, polypeptides and small molecules for applications in large segments of the agricultural, industrial, chemical and biopharmaceutical industries.
3.6
(si*)
>440
5
  • Novartis
  • www.novartis.com
  • Created by the merger of Ciba and Sandoz. Has core businesses in healthcare, agribusiness and consumer health.
4.4
(si*)
>50
7
  • Chronix Biomedical
  • www.chronixbiomedical.com
  • Identifies sentinel nucleic acid expression profiles for use in developing assays associated with the prevention, diagnosis, and treatment of a variety of chronic diseases and catastrophic illnesses. Includes company history, staff and a list of current research projects.
3.4
(si*)
>20
4
  • Biocon, Ltd.
  • www.biocon.com
  • A global healthcare company, focusing on unmet medical needs in cancer, diabetes and inflammatory diseases.
4.2
(si*)
<10
6
  • Genotypic Technology Pvt.Ltd.
  • genotypic.co.in
  • Solutions for drug discovery and research and development for pharma, genomics and biotechnology companies. Details of services and current research projects.
3.7
(si*)
<10
4
  • Benitec
  • www.benitec.com
  • Offers gene silencing platform technology. Including description of RNA interference, resources page and details of commercial licensing opportunities.
3.7
(si*)
<5
5
  • BioSeek Inc.
  • www.bioseekinc.com
  • Develops high throughput biological systems for the validation and development of novel human therapeutics.
3.3
(si*)
<5
4
  • Ceapro, Inc.
  • www.ceapro.com
  • The company utilizes core technologies for the separation and formulation of natural extracts to benefit human and animal health.
3.4
(si*)
<5
4
  • Phage Biotech, Ltd.
  • www.phage-biotech.com
  • Presents a valid biological solution to the chemical antibiotics crisis.
3.3
(si*)
<5
3
  • BioTech Navigator Investment Newsletter
  • www.biotechnav.com
  • Monthly newsletter providing analysis, interpretation, news, and commentary relating to biotechnology industry developments for investing in biotechnology and/or medical stocks.
3.2
(si*)
<5
3
Also see:
Similar categories:
This category in other languages: